Screening for HemochromatosisArchived 6 February 2007 at the Wayback Machine. U.S. Preventive Services Task Force (2006). Summary of Screening Recommendations and Supporting Documents. Retrieved 18 March 2007
Franchini M (March 2006). “Hereditary iron overload: update on pathophysiology, diagnosis, and treatment”. Am. J. Hematol.81 (3): 202–9. doi:10.1002/ajh.20493. PMID16493621.
Janet, R Hunt (June 2009). “Body iron excretion by healthy men and women”. The American Journal of Clinical Nutrition89 (6): 1792–1798. doi:10.3945/ajcn.2009.27439. PMID19386738.
Ofojekwu, Mary-Jane N.; Nnanna, Ogbonnaya U.; Okolie, Charles E.; Odewumi, Lolade A.; Isiguzoro, Ikechukwu O. U.; Lugos, Moses. D. (2013). “Hemoglobin and Serum Iron Concentrations in Menstruating Nulliparous Women in Jos, Nigeria”. Laboratory Medicine44 (2): 121–124. doi:10.1309/LMM7A0F0QBXEYSSI.
Pietrangelo A (June 2004). “Hereditary hemochromatosis—a new look at an old disease”. N. Engl. J. Med.350 (23): 2383–97. doi:10.1056/NEJMra031573. PMID15175440.
“Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs”. Neurology33 (11): 1479–83. (1983). doi:10.1212/WNL.33.11.1479. PMID6685241.
“Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE-related genetic hemochromatosis”. Am. J. Gastroenterol.103 (10): 2502–8. (October 2008). doi:10.1111/j.1572-0241.2008.02036.x. PMID18684194.
“A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis”. Nature Genetics13 (4): 399–408. (1996). doi:10.1038/ng0896-399. PMID8696333.
“A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation”. Gastroenterology122 (3): 646–51. (March 2002). doi:10.1016/s0016-5085(02)80116-0. PMID11874997.
“HFE Genotype and Endurance Performance in Competitive Male Athletes”. Medicine and Science in Sports and Exercise53 (7): 1385–1390. (December 2020). doi:10.1249/MSS.0000000000002595. PMID33433155.
“Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees”. American Journal of Clinical Pathology78 (2): 196–207. (August 1982). doi:10.1093/ajcp/78.2.196. PMID7102818.
St Pierre; Clark, PR; Chua-Anusorn, W; Fleming, AJ; Jeffrey, GP; Olynyk, JK; Pootrakul, P; Robins, E et al. (2005). “Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance”. Blood105 (2): 855–61. doi:10.1182/blood-2004-01-0177. PMID15256427.
Hirsch, J. H.; Killien, F. C.; Troupin, R. H. (March 1976). “The arthropathy of hemochromatosis”. Radiology118 (3): 591–596. doi:10.1148/118.3.591. ISSN0033-8419. PMID175396.
“Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene”. Blood Cells Mol Dis31 (3): 299–304. (2003). doi:10.1016/S1079-9796(03)00164-5. PMID14636642.
Polomoscanik, Steven C.; Cannon, C. Pat; Neenan, Thomas X.; Holmes-Farley, S. Randall; Mandeville, W. Harry; Dhal, Pradeep K. (November 2005). “Hydroxamic Acid-Containing Hydrogels for Nonabsorbed Iron Chelation Therapy: Synthesis, Characterization, and Biological Evaluation”. Biomacromolecules6 (6): 2946–2953. doi:10.1021/bm050036p. PMID16283713.
Qian, Jian; Sullivan, Bradley P.; Peterson, Samuel J.; Berkland, Cory (18 April 2017). “Nonabsorbable Iron Binding Polymers Prevent Dietary Iron Absorption for the Treatment of Iron Overload”. ACS Macro Letters6 (4): 350–353. doi:10.1021/acsmacrolett.6b00945. PMID35610854.
Niederau, Claus; Fischer, Rudolf; Sonnenberg, Amnon; Stremmel, Wolfgang; Trampisch, Hans J.; Strohmeyer, Georg (14 November 1985). “Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis”. New England Journal of Medicine313 (20): 1256–1262. doi:10.1056/NEJM198511143132004. PMID4058506.
Franchini M (March 2006). “Hereditary iron overload: update on pathophysiology, diagnosis, and treatment”. Am. J. Hematol.81 (3): 202–9. doi:10.1002/ajh.20493. PMID16493621.
Janet, R Hunt (June 2009). “Body iron excretion by healthy men and women”. The American Journal of Clinical Nutrition89 (6): 1792–1798. doi:10.3945/ajcn.2009.27439. PMID19386738.
Pietrangelo A (June 2004). “Hereditary hemochromatosis—a new look at an old disease”. N. Engl. J. Med.350 (23): 2383–97. doi:10.1056/NEJMra031573. PMID15175440.
“Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs”. Neurology33 (11): 1479–83. (1983). doi:10.1212/WNL.33.11.1479. PMID6685241.
“Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE-related genetic hemochromatosis”. Am. J. Gastroenterol.103 (10): 2502–8. (October 2008). doi:10.1111/j.1572-0241.2008.02036.x. PMID18684194.
“A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis”. Nature Genetics13 (4): 399–408. (1996). doi:10.1038/ng0896-399. PMID8696333.
“A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation”. Gastroenterology122 (3): 646–51. (March 2002). doi:10.1016/s0016-5085(02)80116-0. PMID11874997.
“HFE Genotype and Endurance Performance in Competitive Male Athletes”. Medicine and Science in Sports and Exercise53 (7): 1385–1390. (December 2020). doi:10.1249/MSS.0000000000002595. PMID33433155.
“Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees”. American Journal of Clinical Pathology78 (2): 196–207. (August 1982). doi:10.1093/ajcp/78.2.196. PMID7102818.
St Pierre; Clark, PR; Chua-Anusorn, W; Fleming, AJ; Jeffrey, GP; Olynyk, JK; Pootrakul, P; Robins, E et al. (2005). “Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance”. Blood105 (2): 855–61. doi:10.1182/blood-2004-01-0177. PMID15256427.
Hirsch, J. H.; Killien, F. C.; Troupin, R. H. (March 1976). “The arthropathy of hemochromatosis”. Radiology118 (3): 591–596. doi:10.1148/118.3.591. ISSN0033-8419. PMID175396.
“Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene”. Blood Cells Mol Dis31 (3): 299–304. (2003). doi:10.1016/S1079-9796(03)00164-5. PMID14636642.
Polomoscanik, Steven C.; Cannon, C. Pat; Neenan, Thomas X.; Holmes-Farley, S. Randall; Mandeville, W. Harry; Dhal, Pradeep K. (November 2005). “Hydroxamic Acid-Containing Hydrogels for Nonabsorbed Iron Chelation Therapy: Synthesis, Characterization, and Biological Evaluation”. Biomacromolecules6 (6): 2946–2953. doi:10.1021/bm050036p. PMID16283713.
Qian, Jian; Sullivan, Bradley P.; Peterson, Samuel J.; Berkland, Cory (18 April 2017). “Nonabsorbable Iron Binding Polymers Prevent Dietary Iron Absorption for the Treatment of Iron Overload”. ACS Macro Letters6 (4): 350–353. doi:10.1021/acsmacrolett.6b00945. PMID35610854.
Niederau, Claus; Fischer, Rudolf; Sonnenberg, Amnon; Stremmel, Wolfgang; Trampisch, Hans J.; Strohmeyer, Georg (14 November 1985). “Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis”. New England Journal of Medicine313 (20): 1256–1262. doi:10.1056/NEJM198511143132004. PMID4058506.
Hemochromatosis-DiagnosisArchived 18 March 2007 at the Wayback Machine. National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
HemochromatosisArchived 18 March 2007 at the Wayback Machine. National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
Reference, Genetics Home. “Hereditary hemochromatosis”. Genetics Home Reference. 16 August 2019時点のオリジナルよりアーカイブ。22 July 2019閲覧。
Hemochromatosis-DiagnosisArchived 18 March 2007 at the Wayback Machine. National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
HemochromatosisArchived 18 March 2007 at the Wayback Machine. National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
“Hemochromatosis: Symptoms”. Mayo Foundation for Medical Education and Research (MFMER). 30 April 2008時点のオリジナルよりアーカイブ。17 March 2007閲覧。
Screening for HemochromatosisArchived 6 February 2007 at the Wayback Machine. U.S. Preventive Services Task Force (2006). Summary of Screening Recommendations and Supporting Documents. Retrieved 18 March 2007
Hirsch, J. H.; Killien, F. C.; Troupin, R. H. (March 1976). “The arthropathy of hemochromatosis”. Radiology118 (3): 591–596. doi:10.1148/118.3.591. ISSN0033-8419. PMID175396.
